down arrow

Medico Remedies

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE630Y01024
  • NSEID: MEDICO
  • BSEID: 540937
INR
57.78
-0.05 (-0.09%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 94.29 k

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

57.2958.75

52 Week

35.0079.78
Valuation
Technical
Day's Volume

CASH

94.29 k (-75.78%) Volume

Shareholding (Dec 2024)

FII

0.39%

Held by 5 FIIs

DII

0.78%

Held by 0 DIIs

Promoter

66.83%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

Strong ability to service debt as the company has a low Debt to EBITDA ratio of 0.96 times

 
2

Poor long term growth as Net Sales has grown by an annual rate of 2.13% over the last 5 years

 
3

Flat results in Dec 24

4

Stock is technically in a Mildly Bullish range

5

With ROCE of 14.7, it has a Expensive valuation with a 7.5 Enterprise value to Capital Employed

6

Reducing Promoter Confidence

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 479 Cr (Micro Cap)

stock-summary
P/E

54.00

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.18

stock-summary
Return on Equity

15.94%

stock-summary
Price to Book

8.65

Revenue and Profits (1 Year):
Net Sales:
39 Cr
(Quarterly Results - Dec 2024)
Net Profit:
3 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
20.38%
0%
20.38%
1 Year
22.49%
0%
22.49%
2 Years
-32.27%
0%
-32.27%
3 Years
261.12%
0%
261.12%
4 Years
1055.6%
0%
1055.6%
5 Years
1461.62%
0%
1461.62%

Medico Remedies for the last several years.

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
2.13%
EBIT Growth (5y)
27.49%
EBIT to Interest (avg)
8.23
Debt to EBITDA (avg)
1.22
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
2.41
Tax Ratio
26.62%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
1.17%
ROCE (avg)
15.56%
ROE (avg)
17.28%
Valuation key factors
Factor
Value
P/E Ratio
54
Industry P/E
33
Price to Book Value
8.65
EV to EBIT
49.08
EV to EBITDA
37.73
EV to Capital Employed
7.49
EV to Sales
3.24
PEG Ratio
2.01
Dividend Yield
NA
ROCE (Latest)
14.74%
ROE (Latest)
15.94%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Mildly Bearish
Dow Theory
No Trend
No Trend
OBV
Mildly Bullish
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 5 FIIs (0.39%)

Promoter with highest holding

Haresh Kapurlal Mehta (20.76%)

Highest Public shareholder

Ravi Goyal HUF (6.6%)

Individual Investors Holdings

18.08%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Dec'24 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Dec 2024 is 32.65% vs -23.37% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in quarter ended Dec 2024 is 80.69% vs -35.56% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "39.49",
          "val2": "29.77",
          "chgp": "32.65%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "3.11",
          "val2": "2.73",
          "chgp": "13.92%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.28",
          "val2": "0.22",
          "chgp": "27.27%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "2.62",
          "val2": "1.45",
          "chgp": "80.69%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "7.88%",
          "val2": "9.17%",
          "chgp": "-1.29%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2024 is -4.98% vs 0.31% in Sep 2023",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": " Growth in half year ended Sep 2024 is -16.53% vs 16.10% in Sep 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "70.15",
          "val2": "73.83",
          "chgp": "-4.98%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "5.23",
          "val2": "5.53",
          "chgp": "-5.42%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.39",
          "val2": "0.35",
          "chgp": "11.43%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "3.13",
          "val2": "3.75",
          "chgp": "-16.53%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "7.46%",
          "val2": "7.49%",
          "chgp": "-0.03%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Standalone) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 5.83% vs -7.87% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 10.58% vs -5.11% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "109.64",
          "val2": "103.60",
          "chgp": "5.83%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "8.34",
          "val2": "8.26",
          "chgp": "0.97%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.67",
          "val2": "0.57",
          "chgp": "17.54%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "5.75",
          "val2": "5.20",
          "chgp": "10.58%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "7.61%",
          "val2": "7.97%",
          "chgp": "-0.36%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is 3.19% vs 16.05% in Mar 2023",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is 14.50% vs 48.06% in Mar 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "144.92",
          "val2": "140.44",
          "chgp": "3.19%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "12.91",
          "val2": "9.62",
          "chgp": "34.20%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.82",
          "val2": "0.75",
          "chgp": "9.33%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "8.29",
          "val2": "7.24",
          "chgp": "14.50%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "8.91%",
          "val2": "6.85%",
          "chgp": "2.06%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Standalone) - Dec'24 - YoYstock-summary
Dec'24
Dec'23
Change(%)
Net Sales
39.49
29.77
32.65%
Operating Profit (PBDIT) excl Other Income
3.11
2.73
13.92%
Interest
0.28
0.22
27.27%
Exceptional Items
0.00
0.00
Standalone Net Profit
2.62
1.45
80.69%
Operating Profit Margin (Excl OI)
7.88%
9.17%
-1.29%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in quarter ended Dec 2024 is 32.65% vs -23.37% in Dec 2023

Direction Arrows
Standalone Net Profit

YoY Growth in quarter ended Dec 2024 is 80.69% vs -35.56% in Dec 2023

All Quarterly Resultsstock-summary
Half Yearly Results Snapshot (Standalone) - Sep'24stock-summary
Sep'24
Sep'23
Change(%)
Net Sales
70.15
73.83
-4.98%
Operating Profit (PBDIT) excl Other Income
5.23
5.53
-5.42%
Interest
0.39
0.35
11.43%
Exceptional Items
0.00
0.00
Standalone Net Profit
3.13
3.75
-16.53%
Operating Profit Margin (Excl OI)
7.46%
7.49%
-0.03%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

Growth in half year ended Sep 2024 is -4.98% vs 0.31% in Sep 2023

Direction Arrows
Standalone Net Profit

Growth in half year ended Sep 2024 is -16.53% vs 16.10% in Sep 2023

All Half Yearly Resultsstock-summary
Nine Monthly Results Snapshot (Standalone) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
109.64
103.60
5.83%
Operating Profit (PBDIT) excl Other Income
8.34
8.26
0.97%
Interest
0.67
0.57
17.54%
Exceptional Items
0.00
0.00
Standalone Net Profit
5.75
5.20
10.58%
Operating Profit Margin (Excl OI)
7.61%
7.97%
-0.36%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is 5.83% vs -7.87% in Dec 2023

Direction Arrows
Standalone Net Profit

YoY Growth in nine months ended Dec 2024 is 10.58% vs -5.11% in Dec 2023

All Nine Monthly Resultsstock-summary
Annual Results Snapshot (Standalone) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
144.92
140.44
3.19%
Operating Profit (PBDIT) excl Other Income
12.91
9.62
34.20%
Interest
0.82
0.75
9.33%
Exceptional Items
0.00
0.00
Standalone Net Profit
8.29
7.24
14.50%
Operating Profit Margin (Excl OI)
8.91%
6.85%
2.06%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2024 is 3.19% vs 16.05% in Mar 2023

Direction Arrows
Standalone Net Profit

YoY Growth in year ended Mar 2024 is 14.50% vs 48.06% in Mar 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Medico Remedies Ltd stock-summary
stock-summary
Medico Remedies Ltd
Micro Cap
Pharmaceuticals & Drugs
Medico Remedies Limited was incorporated as a Private Limited Company with the name "Medico Remedies Private Limited" on March 18, 1994. The status was changed to a Public Limited Company and the Company name was changed to Medico Remedies Limited on March 6, 2017.
Company Coordinates stock-summary
Company Details
1105/1106 11-Flr Hubtown Solar, N S Phadke Marg Andheri East Mumbai Maharashtra : 400069
stock-summary
Tel: 91-22-2670 1055/66
stock-summary
http://www.medicoremedies.com
stock-summary
info@medicoremedies.com
Registrar Details
Cameo Corporate Services Ltd , Subramanian Buildings No 1 , Club House Road, Chennai
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."